Paper134464
The anticoagulant effect of heparan sulfate and dermatan sulfate.
Teien AN and 2 others. Thromb Res, 1976. Cited by 234 papers, by iCite.
Cite this record
ConductScience Library. The anticoagulant effect of heparan sulfate and dermatan sulfate. Papers, record 134464. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/134464
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Coagulation | Major topic |
| Chondroitin | Major topic |
| Dermatan Sulfate | Major topic |
| Glycosaminoglycans | Major topic |
| Heparan Sulfate | Major topic |
| Animals | |
| Antithrombins | |
| Chondroitin Sulfates | |
| Dose-Response Relationship, Drug | |
| Factor X | |
| Heparin | |
| Humans | |
| Hyaluronic Acid | |
| Keratan Sulfate | |
| Thrombin | |
| Thromboplastin |
Source PubMed
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 234 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41012547 | Targeting the Oral Mucosa: Emerging Drug Delivery Platforms and the Therapeutic Potential of Glycosaminoglycans. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41012547 | PubMed |
| 40705086 | The Role of Heparan Sulfate in Bone Repair and Regeneration. | Calcif Tissue Int | 2025 | https://conductscience.org/library/papers/40705086 | PubMed |
| 35518950 | The neutralization of heparan sulfate by heparin-binding copolymer as a potential therapeutic target. | RSC Adv | 2019 | https://conductscience.org/library/papers/35518950 | PubMed |
| 34410575 | COVID-19: the CaMKII-like system of S protein drives membrane fusion and induces syncytial multinucleated giant cells. | Immunol Res | 2021 | https://conductscience.org/library/papers/34410575 | PubMed |
| 33865880 | Antiviral strategies should focus on stimulating the biosynthesis of heparan sulfates, not their inhibition. | Life Sci | 2021 | https://conductscience.org/library/papers/33865880 | PubMed |
| 33729108 | De novo transcriptome reveals blood coagulation/antithrombin factors and infection mechanisms in Angiostrongylus cantonensis adult worms. | Parasitology | 2021 | https://conductscience.org/library/papers/33729108 | PubMed |
| 32377957 | Circulating heparan sulfate chains and body weight contribute to anti-Xa levels in cancer patients using the prophylactic dose of enoxaparin. | J Thromb Thrombolysis | 2020 | https://conductscience.org/library/papers/32377957 | PubMed |
| 26861358 | Marine Origin Polysaccharides in Drug Delivery Systems. | Mar Drugs | 2016 | https://conductscience.org/library/papers/26861358 | PubMed |
| 21152191 | Mesoglycan: clinical evidences for use in vascular diseases. | Int J Vasc Med | 2010 | https://conductscience.org/library/papers/21152191 | PubMed |
| 19102516 | Factors associated with bleeding in elderly hospitalized patients treated with enoxaparin sodium : a prospective, open-label, observational study. | Drugs Aging | 2009 | https://conductscience.org/library/papers/19102516 | PubMed |
| 18281504 | Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II. | Blood | 2008 | https://conductscience.org/library/papers/18281504 | PubMed |
| 17878401 | Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice. | Blood | 2007 | https://conductscience.org/library/papers/17878401 | PubMed |
| 16339402 | Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II. | Blood | 2006 | https://conductscience.org/library/papers/16339402 | PubMed |
| 8136018 | Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor. | J Protein Chem | 1993 | https://conductscience.org/library/papers/8136018 | PubMed |
| 7492320 | Effects of aging on the synthesis of antithrombin-binding sites on heparin chains and heparan sulphate chains in the rat. | Biochem J | 1995 | https://conductscience.org/library/papers/7492320 | PubMed |
| 7378640 | Evidence for antithrombin III involvement in the anticoagulant activity of cellulose sulphate. | Br J Pharmacol | 1980 | https://conductscience.org/library/papers/7378640 | PubMed |
| 7225714 | The anticoagulant activity of dermatan sulphates: evidence against the involvement of antithrombin III. | Br J Pharmacol | 1981 | https://conductscience.org/library/papers/7225714 | PubMed |
| 6802163 | The anticoagulant effect of chondroitin sulphates isolated from normal and atherosclerotic regions of human aortas. | Br J Exp Pathol | 1982 | https://conductscience.org/library/papers/6802163 | PubMed |
| 6508733 | Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. | Biochem J | 1984 | https://conductscience.org/library/papers/6508733 | PubMed |
| 6452123 | Interaction of lipoprotein lipase with native and modified heparin-like polysaccharides. | Biochem J | 1980 | https://conductscience.org/library/papers/6452123 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/134464
GET https://conductscience.org/api/papers/v1/134464/cited_by?page=2